https://www.selleckchem.com/products/Nolvadex.html
High PRAS40 mRNA expression was associated with poor overall survival. Furthermore, Multivariate analysis revealed that PRAS40 was an independent risk factor for ccRCC patients. Myc targets, DNA repair, oxidative phosphorylation, glycolysis, adipogenesis, p53 pathway, reactive oxygen species pathway, myogenesis were differentially enriched in the phenotype that positively correlated with PRAS40. In conclusion, our results suggest that PRAS40 was a promising diagnostic and prognostic biomarker for ccRCC. In conclusion, our results sugge
Like
Comment
Share
